X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ALEMBIC LTD ALKEM LABORATORIES/
ALEMBIC LTD
 
P/E (TTM) x - 116.9 - View Chart
P/BV x 6.6 4.3 152.5% View Chart
Dividend Yield % 0.7 0.3 253.4%  

Financials

 ALKEM LABORATORIES   ALEMBIC LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ALEMBIC LTD
Mar-16
ALKEM LABORATORIES/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,58953 3,009.5%   
Low Rs1,23229 4,204.8%   
Sales per share (Unadj.) Rs417.54.7 8,845.0%  
Earnings per share (Unadj.) Rs56.38.8 641.6%  
Cash flow per share (Unadj.) Rs64.79.0 718.7%  
Dividends per share (Unadj.) Rs12.700.15 8,466.7%  
Dividend yield (eoy) %0.90.4 246.4%  
Book value per share (Unadj.) Rs292.927.7 1,056.5%  
Shares outstanding (eoy) m119.57267.03 44.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.48.7 38.8%   
Avg P/E ratio x25.14.7 535.5%  
P/CF ratio (eoy) x21.84.6 478.1%  
Price / Book Value ratio x4.81.5 325.2%  
Dividend payout %22.61.7 1,319.5%   
Avg Mkt Cap Rs m168,65310,962 1,538.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,171238 3,853.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,9151,260 3,960.6%  
Other income Rs m1,645264 623.6%   
Total revenues Rs m51,5611,524 3,383.0%   
Gross profit Rs m8,48283 10,244.3%  
Depreciation Rs m1,00661 1,638.1%   
Interest Rs m6710 223,533.3%   
Profit before tax Rs m8,451285 2,966.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m1,6066 26,327.9%   
Profit after tax Rs m6,7312,343 287.3%  
Gross profit margin %17.06.6 258.7%  
Effective tax rate %19.02.1 887.6%   
Net profit margin %13.5185.9 7.3%  
BALANCE SHEET DATA
Current assets Rs m27,0621,689 1,602.4%   
Current liabilities Rs m15,324486 3,151.7%   
Net working cap to sales %23.595.4 24.6%  
Current ratio x1.83.5 50.8%  
Inventory Days Days67217 30.7%  
Debtors Days Days4181 50.9%  
Net fixed assets Rs m12,6101,624 776.4%   
Share capital Rs m239534 44.8%   
"Free" reserves Rs m34,4905,960 578.7%   
Net worth Rs m35,0277,404 473.1%   
Long term debt Rs m1,212104 1,161.6%   
Total assets Rs m54,3878,010 679.0%  
Interest coverage x13.6950.7 1.4%   
Debt to equity ratio x00 245.5%  
Sales to assets ratio x0.90.2 583.3%   
Return on assets %13.629.3 46.5%  
Return on equity %19.231.6 60.7%  
Return on capital %24.931.3 79.4%  
Exports to sales %12.92.9 439.7%   
Imports to sales %3.128.9 10.7%   
Exports (fob) Rs m6,46137 17,415.4%   
Imports (cif) Rs m1,540364 423.5%   
Fx inflow Rs m6,56337 17,690.8%   
Fx outflow Rs m3,012365 825.3%   
Net fx Rs m3,552-328 -1,083.3%   
CASH FLOW
From Operations Rs m7,259346 2,100.3%  
From Investments Rs m1,864-48 -3,916.4%  
From Financial Activity Rs m-9,273-301 3,080.6%  
Net Cashflow Rs m-150-3 5,000.0%  

Share Holding

Indian Promoters % 66.9 64.0 104.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.2 16,550.0%  
FIIs % 0.0 9.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 26.1 -  
Shareholders   68,381 54,701 125.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  PLETHICO PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; IT Stocks Rally(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day and ended the day in red.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Why India is Short of Cash Again(Vivek Kaul's Diary)

Apr 19, 2018

It is basically a supply problem with not enough currency going around in the financial system.

A Sure Shot Way to Predict a Multibagger Stock(The 5 Minute Wrapup)

Apr 17, 2018

The imaginary stock price of IIM Ahmedabad could have rivalled the returns from Titan and Asian Paints thanks to its enormous pricing power.

Why Buffett Would Scowl at My Latest Recommendation...(Profit Hunter)

Apr 18, 2018

Warren Buffett's advice that may not be so relevant in these dynamic times, and could do investors more damage than good when taken at the face value.

This is How a Smart Robo-Advisor can Help You Chart Your Asset Allocation...(Outside View)

Apr 16, 2018

PersonalFN explains how a dependable robo-advisory platform can help you create your personalized asset allocation plan

How Retail Investors Often Dump the Best Buying Opportunities(Chart Of The Day)

Apr 16, 2018

A journey into how retail investors have invested since the turn of the millennium and why I don't want to do repeat that mistake ever again...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Apr 25, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS